Join
Live feed
·
INSIDERFilingvia Quantisnow
SpringWorks Therapeutics Inc. logo

Director Lynch Daniel sold $2,866,534 worth of shares (47,600 units at $60.22), decreasing direct ownership by 36% to 82,944 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SWTX· SpringWorks Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SWTX (SpringWorks Therapeutics Inc.) and more on Quantisnow.